Prognostic factors and recurrence in breast cancer: experience at the national cancer institute of Mexico
- PMID: 22830047
- PMCID: PMC3399427
- DOI: 10.5402/2012/825258
Prognostic factors and recurrence in breast cancer: experience at the national cancer institute of Mexico
Abstract
The purpose of this study was to analyze the prognostic and predictive factors that relate to locoregional or distant recurrences in breast cancer patients who have been treated at the National Cancer Institute of Mexico. Multivariate, time-dependent Cox regression analyses indicate that the pN status (positive versus negative lymph node; P = 0.003; HR (hazard ratio), 3.47; CI (confidence interval), 1.52-7.91) and the pathological complete response of the patient to neoadjuvant chemotherapy (yes versus no; P = 0.061; HR, 0.38; CI, 0.14-1.04) were important prognostic factors for recurrence.
Figures
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca-A Cancer Journal for Clinicians. 2005;55(2):74–108. - PubMed
-
- Bland KI, Menck HR, Scott-Connor CE, Morrow M, Winchester DJ, Winchester DP. The National Cancer Date base 10 year survey of breast cancer tretmant at hospitals in the United States. Cancer. 1998;83:1262–1273. - PubMed
-
- Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy:incident and outcomes. Journal of the American College of Surgeons. 2006;203(4):469–474. - PubMed
-
- Fisher B, Bauer M, Wickerham DL. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52(9):1551–1557. - PubMed
-
- Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63(1):181–187. - PubMed
LinkOut - more resources
Full Text Sources
